首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Discovery and molecular characterization of a Bcl-2-regulated cell death pathway in schistosomes
【24h】

Discovery and molecular characterization of a Bcl-2-regulated cell death pathway in schistosomes

机译:血吸虫中Bcl-2调控的细胞死亡途径的发现和分子表征

获取原文
获取原文并翻译 | 示例
       

摘要

Schistosomiasis is an infectious disease caused by parasites of the phylum platyhelminthe. Here, we describe the identification and characterization of a Bcl-2-regulated apoptosis pathway in Schis-tosoma japonicum and 5. mansoni. Genomic, biochemical, and cell-based mechanistic studies provide evidence for a tripartite pathway, similar to that in humans including BH3-only proteins that are inhibited by prosurvival Bcl-2-like molecules, and Bax/Bak-like proteins that facilitate mitochondrial outer-membrane permeabi-lization. Because Bcl-2 proteins have been successfully targeted with "BH3 mimetic" drugs, particularly in the treatment of cancer, we investigated whether schistosome apoptosis pathways could provide targets for future antischistosomal drug discovery efforts. Accordingly, we showed that a schistosome prosurvival protein, sjA, binds ABT-737, a well-characterized BH3 mimetic. A crystal structure of sjA bound to a BH3 peptide provides direct evidence for the feasibility of developing BH3 mimetics to target Bcl-2 pro-survival proteins in schistosomes, suggesting an alternative application for this class of drugs beyond cancer treatment.
机译:血吸虫病是由鸭嘴兽门的寄生虫引起的传染病。在这里,我们描述日本血吸虫和mansoni中Bcl-2调节的凋亡途径的鉴定和表征。基因组,生物化学和基于细胞的机理研究为三方途径提供了证据,与人类相似,包括受生存Bcl-2样分子抑制的仅BH3蛋白质和促进线粒体外部的Bax / Bak样蛋白质。膜通透性。因为Bcl-2蛋白已成功地被“ BH3模拟”药物靶向,尤其是在癌症治疗中,所以我们调查了血吸虫细胞凋亡途径是否可以为未来的抗血吸虫药物研发工作提供靶点。因此,我们显示了血吸虫病的生存蛋白sjA结合了ABT-737,这是一种特征明确的BH3模拟物。与BH3肽结合的sjA的晶体结构为开发BH3模拟物靶向血吸虫中Bcl-2生存前蛋白的可行性提供了直接的证据,这表明该类药物的另一种用途是癌症治疗以外的用途。

著录项

  • 来源
  • 作者单位

    The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia Departments of, University of Melbourne, VIC 3010, Australia,Medical Biology, University of Melbourne, VIC 3010, Australia;

    The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia Departments of, University of Melbourne, VIC 3010, Australia,Medical Biology, University of Melbourne, VIC 3010, Australia;

    The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia Departments of, University of Melbourne, VIC 3010, Australia,Medical Biology, University of Melbourne, VIC 3010, Australia;

    The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia Departments of, University of Melbourne, VIC 3010, Australia,Medical Biology, University of Melbourne, VIC 3010, Australia;

    The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia Departments of, University of Melbourne, VIC 3010, Australia,Medical Biology, University of Melbourne, VIC 3010, Australia;

    Veterinary Science, University of Melbourne, VIC 3010, Australia;

    The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia Departments of, University of Melbourne, VIC 3010, Australia,Medical Biology, University of Melbourne, VIC 3010, Australia;

    Veterinary Science, University of Melbourne, VIC 3010, Australia;

    The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia Departments of, University of Melbourne, VIC 3010, Australia,Medical Biology, University of Melbourne, VIC 3010, Australia;

    The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia Departments of, University of Melbourne, VIC 3010, Australia,Medical Biology, University of Melbourne, VIC 3010, Australia;

  • 收录信息 美国《科学引文索引》(SCI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 00:40:51

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号